Biolife Solutions Receivables

As of the most recent data (June 2026), BLFS shows a receivables of $11M. That compares with $10M in the prior-year period — up 5.9% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, BLFS's receivables is now $11M (was $10M) — a 5.9% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Biolife Solutions is outperforming or lagging.

Tracking BLFS's receivables over time shows whether Biolife Solutions is scaling, shrinking, or reshaping that part of the business. The current reading is $11M That compares with $10M in the prior-year period — up 5.9% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this receivables page, Stockcircle has Biolife Solutions's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect receivables (currently $11M) with ownership activity and broader fundamentals.

Biolife Solutions's receivables is $11M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.